News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Martin Michael Robert
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/06/2023 |
4
| Martin Michael Robert (Chief Business Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns:
| Granted 107,202 shares
@ $0 |
|
11/09/2022 |
4
| Martin Michael Robert (Chief Business Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns:
| Bought 30,000 shares
@ $5.16, valued at
$154.8k
|
|
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2021 |
4
| Martin Michael Robert (Chief Business Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns:
| Sold 50,000 shares
@ $30.17, valued at
$1.5M
Sold 50,000 shares
@ $31.26, valued at
$1.6M
Sold 10,000 shares
@ $30.55, valued at
$305.5k
Exercised 29,000 shares
@ $18.38, valued at
$533k
Sold 29,000 shares
@ $28.82, valued at
$835.8k
Sold 11,000 shares
@ $29.5, valued at
$324.5k
Exercised 29,000 options to buy
@ $0 |
|
11/03/2021 |
4
| Martin Michael Robert (Chief Business Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns:
| Exercised 45,000 shares
@ $3.2, valued at
$144k
Sold 45,000 shares
@ $31.64, valued at
$1.4M
Exercised 45,000 options to buy
@ $0 |
|
09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|